Evidence map›Paper›PMID 42279780›Full record

ArticleFoods (Basel, Switzerland)2026

Raman Spectroscopic Authentication of Rebaudioside M: Discriminating Natural, Fermentation-Derived, and Enzymatically Bioconverted Stevia Sweeteners.

Giuseppe Pezzotti, Akihiro Miyamoto, Takashi Yamashita, Isao Fujita, Akihiro Maeno, Wenliang Zhu, Manabu Nakagawa, Takuya Kobayashi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giuseppe PezzottiBiomedical Engineering Center, Kansai Medical University, 1-9-11 Shin-Machi, Hirakata 573-1191, Japan.ORCID 0000-0002-9663-2429
Akihiro MiyamotoMorita Kagaku Kogyo Co., Ltd., 1-19-18 Inadauemachi, Higashi Osaka 577-0002, Japan.
Takashi YamashitaBiomedical Engineering Center, Kansai Medical University, 1-9-11 Shin-Machi, Hirakata 573-1191, Japan.
Isao FujitaMorita Kagaku Kogyo Co., Ltd., 1-19-18 Inadauemachi, Higashi Osaka 577-0002, Japan.
Akihiro MaenoDepartment of Medical Chemistry, Kansai Medical University, 2-5-1 Shinmachi, Hirakata 573-1010, Japan.
Wenliang ZhuCeramic Physics Laboratory, Kyoto Institute of Technology, Sakyo-Ku, Matsugasaki, Kyoto 606-8585, Japan.
Manabu NakagawaDepartment of Medical Chemistry, Kansai Medical University, 2-5-1 Shinmachi, Hirakata 573-1010, Japan.
Takuya KobayashiDepartment of Medical Chemistry, Kansai Medical University, 2-5-1 Shinmachi, Hirakata 573-1010, Japan.

Funding

Morita Kagaku Kogyo Co. Ltd. None
6 · The paper itself

Abstract

Rebaudioside M (Reb M) is a high-value steviol glycoside responsible for the most desirable sensorial profile among stevia-derived sweeteners, owing to its intense sweetness and near absence of bitter aftertaste. However, its extremely low natural abundance in

Indexed as

authenticationRaman spectroscopyRebaudioside M

Identifiers

PMID42279780
PMCPMC13257270

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.